Lista de obras -

A Qualitative Approach to a Better Understanding of the Problems Underlying Drug Shortages, as Viewed from Belgian, French and the European Union's Perspectives

artículo científico publicado en 2015

Adaptive Pathways: Possible Next Steps for Payers in Preparation for Their Potential Implementation

artículo científico publicado en 2017

Antibiotic consumption and antimicrobial resistance in Poland; findings and implications

article

Barriers for Access to New Medicines: Searching for the Balance Between Rising Costs and Limited Budgets

artículo científico publicado en 2018

Generic pregabalin; current situation and implications for health authorities, generics and biosimilars manufacturers in the future

article

Initiatives to increase the prescribing of low cost generics; the case of Scotland in the international context

article

Medicine Shortages: Gaps Between Countries and Global Perspectives

scientific article published on 19 July 2019

Ongoing strategies to improve the management of upper respiratory tract infections and reduce inappropriate antibiotic use particularly among lower and middle-income countries: findings and implications for the future

scientific article published on 30 December 2019

Over-the-counter medicine and dietary supplement consumption among academic youth in Poland

artículo científico publicado en 2016

Patient Access, Unmet Medical Need, Expected Benefits, and Concerns Related to the Utilisation of Biosimilars in Eastern European Countries: A Survey of Experts.

artículo científico publicado en 2018

Payers' Views of the Changes Arising through the Possible Adoption of Adaptive Pathways

artículo científico publicado en 2016

Perceptions and Attitudes of Egyptian Health Professionals and Policy-Makers towards Pharmaceutical Sales Representatives and Other Promotional Activities

artículo científico publicado en 2015

Pharmacotherapeutic interventions for bipolar disorder type II: addressing multiple symptoms and approaches with a particular emphasis on strategies in lower and middle-income countries

scientific article published on 01 December 2019

Poland: Health System Review

artículo científico publicado en 2019

Practical Implications From European Hospital Pharmacists on Prospective Risk Assessment for Medicine Shortages

artículo científico publicado en 2020

Proposal for a regulation on health technology assessment in Europe - opinions of policy makers, payers and academics from the field of HTA

artículo científico publicado en 2019

Prospective Risk Assessment of Medicine Shortages in Europe and Israel: Findings and Implications

scientific article published on 26 March 2020

Response to the Novel Corona Virus (COVID-19) Pandemic Across Africa: Successes, Challenges, and Implications for the Future

scientific article published on 11 September 2020

Risks in Antibiotic Substitution Following Medicine Shortage: A Health-Care Failure Mode and Effect Analysis of Six European Hospitals

artículo científico publicado en 2020

Systemic Measures and Legislative and Organizational Frameworks Aimed at Preventing or Mitigating Drug Shortages in 28 European and Western Asian Countries.

artículo científico publicado en 2017

The Implementation of Managed Entry Agreements in Central and Eastern Europe: Findings and Implications.

artículo científico publicado en 2017

The transparency of published health technology assessment-based recommendations on pharmaceutical reimbursement in Poland

artículo científico publicado en 2016

Time to Review Authorisation and Funding for New Cancer Medicines in Europe? Inferences from the Case of Olaratumab

scientific article published on 01 February 2020

Lista de obras de

A Qualitative Approach to a Better Understanding of the Problems Underlying Drug Shortages, as Viewed from Belgian, French and the European Union's Perspectives

Adaptive Pathways: Possible Next Steps for Payers in Preparation for Their Potential Implementation

Antibiotic consumption and antimicrobial resistance in Poland; findings and implications

Barriers for Access to New Medicines: Searching for the Balance Between Rising Costs and Limited Budgets

Generic pregabalin; current situation and implications for health authorities, generics and biosimilars manufacturers in the future

Initiatives to increase the prescribing of low cost generics; the case of Scotland in the international context

Medicine Shortages: Gaps Between Countries and Global Perspectives

Ongoing strategies to improve the management of upper respiratory tract infections and reduce inappropriate antibiotic use particularly among lower and middle-income countries: findings and implications for the future

Over-the-counter medicine and dietary supplement consumption among academic youth in Poland

Patient Access, Unmet Medical Need, Expected Benefits, and Concerns Related to the Utilisation of Biosimilars in Eastern European Countries: A Survey of Experts.

Payers' Views of the Changes Arising through the Possible Adoption of Adaptive Pathways

Perceptions and Attitudes of Egyptian Health Professionals and Policy-Makers towards Pharmaceutical Sales Representatives and Other Promotional Activities

Pharmacotherapeutic interventions for bipolar disorder type II: addressing multiple symptoms and approaches with a particular emphasis on strategies in lower and middle-income countries

Poland: Health System Review

Practical Implications From European Hospital Pharmacists on Prospective Risk Assessment for Medicine Shortages

Proposal for a regulation on health technology assessment in Europe - opinions of policy makers, payers and academics from the field of HTA

Prospective Risk Assessment of Medicine Shortages in Europe and Israel: Findings and Implications

Response to the Novel Corona Virus (COVID-19) Pandemic Across Africa: Successes, Challenges, and Implications for the Future

Risks in Antibiotic Substitution Following Medicine Shortage: A Health-Care Failure Mode and Effect Analysis of Six European Hospitals

Systemic Measures and Legislative and Organizational Frameworks Aimed at Preventing or Mitigating Drug Shortages in 28 European and Western Asian Countries.

The Implementation of Managed Entry Agreements in Central and Eastern Europe: Findings and Implications.

The transparency of published health technology assessment-based recommendations on pharmaceutical reimbursement in Poland

Time to Review Authorisation and Funding for New Cancer Medicines in Europe? Inferences from the Case of Olaratumab

[The role of the cytostatic drugs unit in rationalization of hospital drugs management--the case study and the analysis of drug utilization]